Testosterone therapy with Testopel® and the Esoterix Laboratory assay: A CASE study
We present a patient receiving Testopel® implants whose serum testosterone levels, as measured by a CDC certified assay, were accurately predicted by a multi-compartmental model. This is the first time a model has predicted measured serum testosterone levels within 4% of values calculated. To our kn...
Main Authors: | David Seitman, Joseph Fallon, Barry Kimmel |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-09-01
|
Series: | Urology Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2214442021001546 |
Similar Items
-
Subcutaneous testosterone pellet therapy for reversal of male osteoporosis: a review and case report
by: Bruce Dorr, et al.
Published: (2023-12-01) -
Testosterone replacement therapy and cardiovascular events
by: Alp Burak Çatakoğlu, et al.
Published: (2017-10-01) -
Normalization of Testosterone Levels After Testosterone Replacement Therapy Is Associated With Decreased Incidence of Atrial Fibrillation
by: Rishi Sharma, et al.
Published: (2017-05-01) -
Breast Cancer Incidence Reduction in Women Treated with Subcutaneous Testosterone: Testosterone Therapy and Breast Cancer Incidence Study
by: Gary Donovitz, et al.
Published: (2021-04-01) -
Association of subcutaneous testosterone pellet therapy with developing secondary polycythemia
by: Katherine Lang Rotker, et al.
Published: (2018-01-01)